The e-Symptom Management using Advanced Symptom Management System Remote Technology (eSMART) is funded by the European Commission’s Seventh Framework Programme (Project N° 602289). Τhe clinical trial aims to evaluate the impact of a mobile phone-based, remote monitoring, symptom management intervention (Advanced Symptom Management System, ASyMS) on the delivery of care to people diagnosed with non metastatic breast, colorectal or haematological cancer during chemotherapy and for one year after treatment.
Patients have a prominent co-researcher role in eSMART and participate in all project activities from project concept to implementation. ECPC, in its patient representative role participates equally with other researchers within the eSMART Project Technical Management Board, the Publications Committee, and the Exploitation Committee, offering advice and feedback to ensure that the trial is designed and conducted in line with patients’ needs and preferences.
The July-August 2015 Newsletter of the EU funded project eSMART has interesting content:
- Dr. Morven Miller and Dr. Lisa McCann, University of Surrey, explain ASyMS (Advance Symptom Monitoring System) and how it evolved from WiseCare and WiseCare+ two cancer nursing studies in 1997-2003;
- Kathi Apostolidis, ECPC Vice President, writes about the emergence of patients as co-researchers;
- Prof. Nora Kearney, University of Surrey, attended ECPC’s Annual General Meeting in Brussels in June and chaired the Session on Clinical Trials. She presented “eSMART: mHealth in Cancer Supportive Care”;
- Jana Pelouchova, ECPC Secretary and Dr. Annegret Schneider, University of Surrey, report about presenting eSMART at two important conferences in June: respectively the Annual Meeting in Cancer Supportive Care/MASCC/ISOO and The King’s Fund Digital Health and Care Congress.
You may also access previous issues of the eSMART Newsletter here.